StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Getting excited for the week ahead

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Mar 21, 2021 5:53pm

165 Views

Post# 32847633

RE:RE:RE:Getting excited for the week ahead

LithLover wrote: Agree 100%. There is a reason that nothing is leaked or that any updates have come out. Tripp is going to release a very comprehensive roll out. I suggest it will include partnerships, an update to the website, information on how to order for physicians and a full marketing plan.

They have had months and millions of dollars to get this lined up.

It will be huge. It;s what Tripp has been leading up to for years. Finally his time to tell the world and prove all the naysayers, shorters and toxic fiannciers wrong.

frewil11 wrote: Absolutely North , there is no way they will just say Aristotle is launched , they will have partnerships abd commitments announced.

Getting way ahead of the situation here but would love some feedback on a potential issue for down the road.

In the event of an eventual takeover or partnership-merger, I know that actual shares are accorded a new elevated sp as per any agreement. However, are warrants treated the same in such scenarios - in other words does their value increase as well similar to the actual common shares in a buyout scenario - I know there are not voting rights and the like and assume they would be treated equally to common shares.